Dataset Information

Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing ?? and ??T cells.

ABSTRACT: Following infusion of the anti-CD28 superagonist monoclonal antibody TGN1412, three of six previously healthy, young male recipients developed gastrointestinal irritability associated with increased expression of 'gut-homing' integrin ?7 on peripheral blood ??T cells. This subset of patients with intestinal symptoms also displayed a striking and persistent expansion of putative V?2+ ??T cells in the circulation which declined over a 2-year period following drug infusion, concordant with subsiding gut symptoms. These data demonstrate that TGN1412-induced gastrointestinal symptoms were associated with dysregulation of the 'gut-homing' pool of blood ?? and ??T cells, induced directly by the antibody and/or arising from the subsequent cytokine storm.

SUBMITTER: McCarthy NE

PROVIDER: S-EPMC7552579 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing αβ and γδT cells.

McCarthy Neil E NE Stagg Andrew J AJ Price Claire L CL Mann Elizabeth R ER Gellatly Nichola L NL Al-Hassi Hafid O HO Knight Stella C SC Panoskaltsis Nicki N

Cancer immunology, immunotherapy : CII 20201013 4

Following infusion of the anti-CD28 superagonist monoclonal antibody TGN1412, three of six previously healthy, young male recipients developed gastrointestinal irritability associated with increased expression of 'gut-homing' integrin β7 on peripheral blood αβT cells. This subset of patients with intestinal symptoms also displayed a striking and persistent expansion of putative Vδ2<sup>+</sup> γδT cells in the circulation which declined over a 2-year period following drug infusion, concordant wi ...[more]

PMID: 33048222

Similar Datasets

Project description:Cytokine storm can result from cancer immunotherapy or certain infections, including COVID-19. Though short-term immune-related adverse events are routinely described, longer-term immune consequences and sequential immune monitoring are not as well defined. In 2006, six healthy volunteers received TGN1412, a CD28 superagonist antibody, in a first-in-man clinical trial and suffered from cytokine storm. After the initial cytokine release, antibody effect-specific immune monitoring started on Day?+?10 and consisted mainly of evaluation of dendritic cell and T-cell subsets and 15 serum cytokines at 21 time-points over 2 years. All patients developed problems with concentration and memory; three patients were diagnosed with mild-to-moderate depression. Mild neutropenia and autoantibody production was observed intermittently. One patient suffered from peripheral dry gangrene, required amputations, and had persistent Raynaud’s phenomenon. Gastrointestinal irritability was noted in three patients and coincided with elevated ??T-cells. One had pruritus associated with elevated IgE levels, also found in three other asymptomatic patients. Dendritic cells, initially undetectable, rose to normal within a month. Naïve CD8+ T-cells were maintained at high levels, whereas naïve CD4+ and memory CD4+ and CD8+ T-cells started high but declined over 2 years. T-regulatory cells cycled circannually and were normal in number. Cytokine dysregulation was especially noted in one patient with systemic symptoms. Over a 2-year follow-up, cognitive deficits were observed in all patients following TGN1412 infusion. Some also had signs or symptoms of psychological, mucosal or immune dysregulation. These observations may discern immunopathology, treatment targets, and long-term monitoring strategies for other patients undergoing immunotherapy or with cytokine storm. Electronic supplementary material The online version of this article (10.1007/s00262-020-02725-2) contains supplementary material, which is available to authorized users.

Dataset Information

Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing ?? and ??T cells.

Publications

Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing αβ and γδT cells.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure